Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease [1]

American Journal of Gastroenterology

Volumn 101, Issue 6, 2006, Pages 1396-

  Kadayifci, Abdurrahman ^a   Merriman, Raphael B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; METFORMIN;

CONTROLLED STUDY; DIET; HUMAN; LETTER; LIVER BIOPSY; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BIOPSY; BODY MASS INDEX; DIET, REDUCING; FATTY LIVER; FEMALE; HEPATITIS; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; METABOLIC SYNDROME X; METFORMIN; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN E;

EID: 33744789739     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00595_1.x     Document Type: Letter

References (2)

1. Bugianesi E Gentilcore E Manini R, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005 100 : 1082 90.
2. Uygun A Kadayifci A Isik AT, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2004 19 : 537 44.